Genius Group Limited - GNS STOCK NEWS

Helbiz (NASDAQ: HLBZ) is investigating illegal short selling activities that have impacted its stock price. The Board of Directors is considering legal action and partnerships, taking cues from Genius Group (NYSE American: GNS). CEO Salvatore Palella emphasized that these activities have led to a decreased stock value and prompted challenging decisions, including layoffs. Helbiz aims to protect its shareholders' interests and restore fair market conditions.

The Board of Directors of Genius Group Limited (NYSE American: GNS) has initiated an action plan targeting alleged illegal short selling of its stock. This includes forming a Board-led ‘Illegal Trading Task Force’ to collaborate with regulators on market manipulation matters. Legal proceedings against involved parties will be pursued, alongside plans for a special dividend to shareholders to help reveal manipulators. Additionally, a dual listing is being considered to mitigate short selling risks. An Extraordinary General Meeting will soon be held to gain shareholder approval for these initiatives and potential stock restructuring.

Genius Group Limited (GNS) has signed a non-binding term sheet with Global Corporate Finance for up to US$7.5 million in at-the-market financing. This financing involves the issuance of ordinary shares at a price equivalent to the lowest calculated VWAP minus an 8% discount. The shares will be issued in tranches over a 30-month term, with a $150,000 commitment fee. The proceeds are intended for corporate purposes and expansion strategies. A definitive agreement is expected within 30 days.

Genius Group Limited (AMEX:GNS) has announced initial findings of an investigation by Christian Levine Law Group and Warshaw Burstein, LLP, revealing that certain individuals or companies may have engaged in illegal stock sales to manipulate the company's share price. This scheme appears aimed at artificially depressing the stock value. Genius Group plans to pursue all available legal remedies against those responsible for the alleged manipulation, reaffirming its commitment to protecting shareholder interests and maintaining market integrity.

Genius Group Limited (AMEX:GNS) has announced a virtual investor meeting on January 10, 2022, at 8:00 a.m. EST. CEO Roger Hamilton will discuss business updates and address shareholder questions, submitted in advance to investor@geniusgroup.net. The meeting aims to engage with shareholders and provide insights into the company's operations.

Genius Group is focused on revolutionizing education through an entrepreneurial Edtech approach, reaching a user base of 4.3 million worldwide.

Genius Group Limited (NYSE American: GNS) reported financial results for the nine months ended September 30, 2022. Revenue grew to $14.42 million, reflecting a 60.68% increase year-over-year. Gross margin improved to 33.96%, compared to 32.95% in the prior year. However, the company faced a net loss of ($6.09 million) and an EBITDA net loss of ($3.89 million). The number of students increased to 3.01 million, with paying students reaching 41,282, marking a 14% annual growth. The firm maintains a pro forma revenue guidance of $35.0m-$38.0m.

Genius Group Limited (GNS) will report its third quarter 2022 financial results on November 30, 2022, before the market opens. A live webcast will be hosted at 8:00 a.m. EST to discuss the results, available on the investor relations section of the Genius Group website. The company, a leader in Edtech with over 4.2 million students across 200 countries, aims to transform education through a student-centered curriculum focused on life skills and entrepreneurship.

Genius Group Limited (NYSE American: GNS) reported strong financial results for H1 2022, with revenue growing 17.18% to $7.44 million compared to H1 2021. Pro forma revenue reached $16.57 million, and gross margin improved to 29.97% from 25.85%. However, the company recorded a net loss of $3.50 million, with an EBITDA loss of $1.96 million. The student base grew to 2.8 million, with 39,124 paying students, reflecting a 9.44% annualized growth. The company maintained its 2022 pro forma adjusted EBITDA guidance, anticipating revenue between $35.0m-$38.0m.